#United States #Bellevue #OSR Holdings #Biomedical Innovations #Virtual Investor Event

OSR Holdings: Aimed at Transparency and Growth

OSR Holdings, Inc. (NASDAQ: OSRH), a prominent figure in the healthcare sector, is gearing up for a significant virtual investor event scheduled for August 6, 2025. Set to unfold at 8:00 AM Eastern Time, this occasion promises to deliver critical updates related to the company’s strategic directions, performance across its subsidiaries, and insights into its development pipeline. Shareholders and potential investors are encouraged to engage during this crucial conversation.

Event Details

The details of the event are meticulously laid out, catering to audiences across different time zones. Eastern Time denotes the start at 8:00 AM, aligning with 2:00 PM Central European Summer Time and 9:00 PM Korea Standard Time. This accessibility exemplifies OSR Holdings’ commitment to inclusivity and openness with stakeholders. Registration for the event opens on August 4, and interested parties can access it via the company’s website. Following the event, a replay will be available, ensuring that no one misses out on important discussions and announcements.

Agenda Overview

The event's agenda is designed to address legacies and innovations that drive OSR Holdings forward. Highlights include:

• - A comprehensive overview of the company's strategic vision;
• - Up-to-date insights into subsidiary and R&D pipeline activities;
• - Detailed discussions on novel products such as Vaximm’s antigen-specific in vivo T-cell immunotherapies, which are tailored to enhance immune responses;
• - A spotlight on Darnatein DRT101, recognized as a potent candidate in disease-modifying osteoarthritis drug development;
• - Insights regarding the Woori IO acquisition, shedding light on opportunities for creating noninvasive continuous glucose monitoring (CGM) technologies;
• - Strategies regarding their Equity Line of Credit (ELOC) financing;
• - The blockchain tokenization approach aimed at elevating transparency and operational efficiency.

The session aims to include a live Q&A, providing a platform for direct interaction with the senior management team, ensuring that concerns and inquiries from stakeholders are addressed timely.

Leader's Vision

Peter Hwang, the CEO of OSR Holdings, emphasizes the significance of this event, positioning it as a pivotal moment for shareholder engagement. He articulates, "This event is a timely opportunity to engage with our shareholders and the broader investment community as we move into a transformative stage in OSR's growth." His words underline the commitment of OSR to transparency and disciplined execution while creating value for stakeholders in the upcoming phases.

Featured Speakers

The event will feature key figures from OSR Holdings, including:

• - Peter Hwang - Chief Executive Officer
• - Dr. Constance Höfer - Chief Scientific Officer
• - Tim Smith - Global Investor Relations

About OSR Holdings, Inc.

OSR Holdings is a leader in the global healthcare sector, dedicated to pushing the boundaries of biomedical innovation to enhance health outcomes worldwide. With a diversified portfolio across immuno-oncology, regenerative biologics, and medical device distribution, OSR aims to improve patient care through cutting-edge research and development initiatives. The organization's vision is manifest in its commitment to acquire and operate a range of innovative healthcare companies, realigning strategic goals towards better global health metrics. For more detailed insights, visit www.OSR-Holdings.com.

As OSR Holdings prepares for this decisive event, the focus remains on progressing towards innovative healthcare solutions, underscoring its dedication to stakeholders and the continuous pursuit of impactful biomedical advancements.